Drug intelligence / Profile preview

mlc901

Development stage
Phase 4
Lead developer
Moleac
Modality
Small Molecules
Administration
Oral
01

Overview

MLC901 (NeuroAiD II) is a traditional Chinese medicine-based herbal formulation composed of nine plant ingredients. It is developed as a neurorestorative and neuroprotective agent, primarily for use in neurological recovery following stroke and traumatic brain injury. The mechanism of action includes enhancement of endogenous neuroprotection, promotion of neurogenesis and neuroplasticity, and activation of KATP channels which confer protection against brain ischemia. MLC901 has demonstrated both neuroprotective and regenerative effects in preclinical models as well as clinical studies for conditions such as stroke, traumatic brain injury (TBI), cognitive impairment after TBI, hypoxic-ischemic brain injury, spinal cord injuries, dementia including Alzheimer's disease, and cognitive dysfunction[3][4][6][8]. Clinical trials have shown improvements in some functional outcomes and cognitive domains post-TBI; however, results are mixed regarding its efficacy compared to placebo for post-stroke recovery[4][9][10]. Common side effects include gastrointestinal discomforts such as nausea or diarrhea; serious adverse events are rare but have been reported.

Brand names
NeuroAiD II
Other names
Neuroaid IIMLC601 (related but distinct predecessor)Danqi Piantan Jiaonang (Chinese approval name)
02

Targets

KATP channel (ATP-sensitive potassium channel)

Beyond the preview

Go deeper on mlc901.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mlc901.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call